Influence of apoptotic and necrotic tumour cells on tumour growth and the prevalence of CD4+ CD25high regulatory T cells

被引：0
|
作者：
Haywood-Small, S. L. [1 ]
Hopkinson, K. [2 ]
Stephenson, T. J. [3 ]
Reed, M. W. R. [4 ]
Woodroofe, N. [1 ]
Brown, N. J. [4 ]
Pockley, A. G. [4 ]
机构：
[1] Sheffield Hallam Univ, Biomed Res Ctr, Sheffield S1 1WB, S Yorkshire, England
[2] Univ Sheffield, Sch Med, Dept Cardiovasc Sci, Sheffield, S Yorkshire, England
[3] Sheffield Teaching Hosp NHS Fdn Trust, Royal Hallamshire Hosp, Dept Histopathol, Sheffield, S Yorkshire, England
[4] Univ Sheffield, Sch Med, Dept Oncol, Sheffield, S Yorkshire, England
来源：
IMMUNOLOGY | 2010年 / 131卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：112 / 113
页数：2
相关论文
共 50 条
  • [41] CD4+ CD25+ regulatory T cells:: towards therapeutic immunomodulation?
    Solomon, B
    M S-MEDECINE SCIENCES, 2002, 18 (11): : 1066 - 1068
  • [42] TGF-beta and CD4+ CD25+ regulatory T cells
    Huber, S
    Schramm, C
    FRONTIERS IN BIOSCIENCE-LANDMARK, 2006, 11 : 1014 - 1023
  • [43] Treatment of human naive T cells with anti-CD4 mAb Max.16H5 induce suppressiveproperties comparable to CD4+/CD25high regulatory T cells.
    不详
    IMMUNOBIOLOGY, 2004, 209 (4-6) : 488 - 488
  • [44] Suppression of tumour-specific CD4+ T cells by regulatory T cells is associated with progression of human colorectal cancer
    Betts, Gareth
    Jones, Emma
    Junaid, Syed
    El-Shanawany, Tariq
    Scurr, Martin
    Mizen, Paul
    Kumar, Mayur
    Jones, Sion
    Rees, Brian
    Williams, Geraint
    Gallimore, Awen
    Godkin, Andrew
    GUT, 2012, 61 (08) : 1163 - 1171
  • [45] CD4(+)CD25high regulatory T cells increase with tumor stage in patients with gastric and esophageal cancers
    Kono, Koji
    Kawaida, Hiromichi
    Takahashi, Akihiro
    Sugai, Hidemitsu
    Mimura, Kosaku
    Miyagawa, Naoto
    Omata, Hideo
    Fujii, Hideki
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2006, 55 (09) : 1064 - 1071
  • [46] CD4(+)CD25high regulatory T cells increase with tumor stage in patients with gastric and esophageal cancers
    Koji Kono
    Hiromichi Kawaida
    Akihiro Takahashi
    Hidemitsu Sugai
    Kosaku Mimura
    Naoto Miyagawa
    Hideo Omata
    Hideki Fujii
    Cancer Immunology, Immunotherapy, 2006, 55 : 1064 - 1071
  • [47] CD4+ CD25 high regulatory T cells reduce transendothelial migration of T cells from cancer patients
    Enarsson, Karin
    Stenstad, Hanna
    Lundin, Samuel
    Johnsson, Erik
    Brezicka, Thomas
    Quiding-Jarbrink, Marianne
    SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 2008, 68 (02) : 210 - 210
  • [48] Conversion of CD4+ CD25- cells into CD4+ CD25+ regulatory T cells in vivo requires B7 costimulation, but not the thymus
    Liang, S
    Alard, P
    Zhao, Y
    Parnell, S
    Clark, SL
    Kosiewicz, MM
    JOURNAL OF EXPERIMENTAL MEDICINE, 2005, 201 (01): : 127 - 137
  • [49] Induction of CD4+ CD25+ T Regulatory Cells with CD103 Depletion
    Zikri, Nancy N.
    Schumer, Erin
    Wang, Jiao-Jing
    Gaughan, Alice
    Hadley, Gregg A.
    Moffatt-Bruce, Susan D.
    JOURNAL OF SURGICAL RESEARCH, 2010, 163 (01) : 162 - 168
  • [50] Distinct molecular program imposed on CD4+ T cell targets by CD4+ CD25+ regulatory T cells
    Sukiennicki, Teresa L.
    Fowell, Deborah J.
    JOURNAL OF IMMUNOLOGY, 2006, 177 (10): : 6952 - 6961
12345